ADHD Stimulants Can Be Safely Prescribed Via Telehealth, Study Argues
By Dennis Thompson HealthDay Reporter

MONDAY, June 16, 2025 — People with ADHD might be prescribed their meds remotely without increasing their risk of addiction, a new study says.
Experts have worried that prescribing stimulants like Adderall through telehealth visits might increase substance abuse among people with attention-deficit/hyperactivity disorder (ADHD).
But this study found no increased risk among ADHD patients prescribed their meds via telehealth versus those who got their scrips at an in-person visit, according to results published June 11 in the American Journal of Psychiatry.
“Our study suggests that, generally, telehealth-based relationships – which make health care more accessible – can be safe and don’t increase the risk of substance use disorder,” lead researcher Dr. Vinod Rao, medical director of adult ambulatory psychiatry at Massachusetts General Hospital in Boston, said in a news release.
For the study, researchers tracked nearly 8,000 patients treated for ADHD at Massachusetts General Hospital between March 2020 and August 2023, a time during which many doctors pivoted to telehealth due to the COVID-19 pandemic.
About 46% of the patients had an in-person appointment on the day their first stimulant was prescribed, results show.
Overall, about 91% of patients had at least one in-person visit with their doctor prior to their first prescription, while 9% had a telehealth-only relationship with their doc.
Patients who never met their doc in person were not more likely to develop a substance use disorder, results show.
The study did find patients who got their first stimulant prescription through telehealth were at a sixfold higher risk of stimulant addiction, after researchers adjusted for other risk factors.
In all, 19 patients total wound up with a stimulant use disorder, which means this finding could be coincidental, researchers said.
It could be that people who opt for telehealth care already have a higher risk for substance use disorder, rather than telehealth causing their increased risk, researchers said.
“While we think the findings should be replicated, the vast majority of the data show no increase in substance use disorder developing when patients exclusively use telehealth,” senior researcher Dr. Timothy Wilens, co-director of the Center for Addiction Medicine at MGH, said in a news release. “Our study supports the use of telehealth for ADHD stimulant therapy in clinical settings.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-17 06:22
Read more

- New Antibody Shot, Enflonsia, Could Help Protect Babies From RSV
- RFK Jr. Installs Critics on Vaccine Recommendation Panel
- Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis
- Johnson & Johnson’s Dual-Targeting CAR T-Cell Therapy Shows Encouraging First Results in Large B-Cell Lymphoma
- AI Boosts Skin Cancer Diagnoses, Study Says
- Worse Outcomes Seen for Unvaccinated Patients Hospitalized With COVID-19, AKI
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions